TRT And Prostate Health: What Men In Canada Should Know About Risk And Safety

Written by the UPGUYS Editorial Team

Published on July 30, 2025

For many men over 40, the idea of starting testosterone replacement therapy (TRT) in Canada sparks a mix of interest and hesitation. One of the most common concerns? 

Testosterone Replacement Therapy

UPGUYS: Online, Easy & Discreet

Start TRT Program Now



Prostate health. Despite growing awareness of low testosterone symptoms—like fatigue, low libido, and loss of muscle—fears about prostate cancer often cause men to delay or avoid treatment altogether. This fear isn’t without history: for decades, testosterone was believed to fuel prostate cancer growth. But modern research tells a different story. 

Today’s evidence shows that medically supervised TRT does not increase the risk of prostate cancer—and may even offer benefits when carefully monitored. 

In this article, we’ll break down where the fear started, what the science now shows, and how men in Canada can safely approach hormone therapy without compromising their long-term health. 

Topics covered in this article: 

Where the Fear Began: The Androgen Hypothesis 

The widespread concern linking testosterone therapy to prostate cancer can be traced back to a theory known as the androgen hypothesis. This idea was first proposed in the 1940s, after research showed that reducing testosterone in men with prostate cancer helped slow tumor growth. From that, the assumption took hold: more testosterone must fuel cancer, and any therapy increasing it could be dangerous. 

Testosterone Replacement Therapy

UPGUYS: Online, Easy & Discreet

Start TRT Program Now

For decades, this belief went largely unchallenged. Doctors avoided prescribing testosterone to men with any history or risk of prostate issues, and patients were warned about the potential link. However, this theory was based on limited early research—not large-scale clinical trials. It failed to account for a key concept: once prostate cells have adequate levels of testosterone to grow, adding more doesn’t necessarily make them grow faster. This is now known as the saturation model, and it's reshaped how experts view testosterone's effect on the prostate. 

Today, researchers and Canadian health professionals recognize that the androgen hypothesis oversimplified the relationship between testosterone and prostate cancer. While caution is still warranted, current evidence shows that testosterone therapy—when monitored—is far less risky than once believed. 

What the Research Shows: Meta‑Analyses & Clinical Trials 

Modern science has thoroughly challenged outdated fears that TRT increases prostate cancer risk. Multiple high-quality meta-analyses and randomized controlled trials now make clear: testosterone replacement therapy (TRT) is not linked to a higher risk of prostate cancer, as long as treatment is clinically supervised. 

Here’s what the evidence indicates: 

1. A major meta‑analysis reviewing various modes of TRT administration found no statistically significant increase in prostate cancer incidence—even when analyzing short- and longer-term therapy data. Odds ratios hovered around 1 across formulations, demonstrating statistical neutrality in cancer risk. 
2. A comprehensive 2024 review encompassing 23 randomized trials showed that TRT does not promote prostate growth, does not raise PSA levels outside normal ranges, and does not worsen urinary symptoms—across patients with and without baseline prostate enlargement. 
3. A population-scale meta-analysis by leading urologists found no link between boosted testosterone levels and increased prostate cancer risk, even in otherwise healthy male subjects. The study concluded that testosterone levels neither increased nor decreased general prostate cancer rates. 

Collectively, this body of evidence supports the widely accepted saturation model, which clarifies that additional testosterone does not fuel prostate cancer once cellular androgen receptors are already saturated. These findings align with Canadian and international guidelines: men with clinically confirmed low testosterone can pursue TRT safely under regular medical oversight. 

Canadian Guidelines: What Urologists Say About TRT and Prostate Safety 

Canadian medical guidelines have evolved alongside the growing body of evidence showing that testosterone replacement therapy (TRT), when properly prescribed, does not increase prostate cancer risk in men with no active disease. The Canadian Urological Association (CUA) and other expert bodies now take a more balanced and evidence-based approach to TRT and prostate health. 

Here’s what leading Canadian urologists and guidelines emphasize: 

1. TRT is not contraindicated for most men with normal PSA levels and no history of prostate cancer. According to the CUA, men with age-related low testosterone and stable prostate health can begin TRT with proper monitoring. 
2. Baseline and ongoing PSA testing is essential. Before starting TRT, men should undergo a prostate-specific antigen (PSA) test and digital rectal exam (DRE). Once on therapy, PSA should be monitored every 6–12 months. A sudden or significant rise may warrant further evaluation but is not, on its own, a reason to stop treatment. 
3. Prostate cancer survivors may still be candidates for TRT, depending on individual risk and treatment history. Some Canadian clinicians now cautiously offer TRT to select men with prior prostate cancer, especially if they are in remission and experiencing significant hypogonadal symptoms—though this remains a case-by-case decision. 
4. Shared decision-making is key. Canadian providers are encouraged to walk patients through the risks, benefits, and alternatives of therapy. TRT is seen not as a one-size-fits-all intervention, but as a medical decision that should align with the patient’s values and health goals. 

In summary, testosterone therapy in Canada is not off-limits due to prostate concerns, but it does require careful screening and follow-up. When managed by an experienced clinician, TRT can be part of a safe, evidence-based plan that supports long-term health in men over 40. 

Testosterone Replacement Therapy

UPGUYS: Online, Easy & Discreet

Start TRT Program Now

Monitoring Tips: PSA Tests, DRE, Shared Decision-Making 

Safe and effective testosterone replacement therapy (TRT) requires consistent monitoring—especially when it comes to prostate health. In Canada, best practices emphasize proactive screening and open communication between patient and provider to ensure long-term safety. 

Here’s what monitoring typically involves: 

1. PSA Testing: Before starting TRT, men should have a baseline prostate-specific antigen (PSA) test. After therapy begins, PSA levels should be re-checked at 3–6 months, then annually. A sharp rise (usually over 1.4 ng/mL in a year) or a total PSA over 4.0 ng/mL may require referral to a urologist for further investigation—not necessarily to stop TRT, but to rule out other issues. 
2. Digital Rectal Exam (DRE): While not always required at every visit, most clinicians recommend a DRE as part of the initial assessment, and periodically afterward, especially for men over 50 or with elevated PSA. It allows your provider to feel for any irregularities in the prostate gland that may not show up in bloodwork. 
3. Shared Decision-Making: Monitoring isn’t just about numbers—it’s also about context. Canadian clinicians are increasingly focused on shared decision-making: involving men in weighing the benefits of TRT against any potential risks, discussing test results clearly, and adjusting the treatment plan based on individual goals and evolving health needs. 

By staying engaged in your care—getting regular tests, keeping open communication with your doctor, and reporting any symptoms or changes—you can use TRT safely while maintaining peace of mind about prostate health. 

Who Benefits Most Safely: When TRT Is Appropriate and How to Approach It 

Testosterone replacement therapy (TRT) isn't for everyone—but for the right candidates, it can offer meaningful improvements in energy, libido, mood, and muscle maintenance without compromising prostate health. The key is identifying who can benefit most safely and responsibly. 

Men most likely to benefit from TRT include those who: 

1. Have clinically low testosterone levels, confirmed by two morning blood tests 
2. Experience persistent symptoms such as fatigue, low libido, poor concentration, or reduced muscle mass 
3. Do not have active prostate cancer or unexplained elevated PSA levels 
4. Are willing to undergo regular monitoring, including PSA and blood work 
5. Have realistic expectations, understanding that TRT supports—not reverses—aging 

In Canada, most clinics and physicians follow strict diagnostic and screening protocols before prescribing TRT. The goal is not just to increase testosterone levels but to improve quality of life in a safe, sustainable way. 

Testosterone Replacement Therapy

UPGUYS: Online, Easy & Discreet

Start TRT Program Now



If you’re unsure whether TRT is right for you, speak to a licensed provider who can assess your hormone levels, medical history, and personal goals. TRT works best when it’s part of a bigger plan—one that includes medical supervision, lifestyle improvements, and ongoing dialogue about risks and benefits. 

Conclusion 

For decades, testosterone and prostate health have been unfairly linked in the public mind. But today, the science tells a different story: when prescribed appropriately and monitored regularly, testosterone replacement therapy (TRT) is not inherently risky for the prostate. In fact, leading research and Canadian medical guidelines now support its use in men with confirmed low T—provided routine PSA tests and clinical evaluations are in place. 

Fear should never stand in the way of reclaiming your well-being. If you’re a man in Canada concerned about low testosterone, the best course is not to avoid treatment, but to pursue it the right way: with education, supervision, and smart long-term care. Prostate health and hormone health can coexist—and for many men, that balance is what makes life after 40 stronger, clearer, and more fulfilling. 

Frequently Asked Questions (FAQs)